Alternatives to Xaira Therapeutics

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

Building foundational AI superintelligence to accelerate scientific knowledge discovery and breakthroughs across complex domains.

Zyvorx is a biotechnology company using AI and computational biology to accelerate drug discovery and development.

Leveraging the adaptive immune system to diagnose and treat disease.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

AI-powered platform for personalized cell therapy development and manufacturing.

Advance every cancer decision.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Biotech company focused on designing and developing novel biological solutions.

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

AI-powered platform for antibody discovery and development to create new medicines.

Biotechnology company

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

Valthos is an applied biological intelligence company. We develop and deploy software and AI methods to outsmart biological evolution and ensure that these tools are deployed to safeguard humanity.

Narya Bio is developing novel therapeutic antibodies for challenging diseases.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

A global oncology company developing and commercializing innovative cancer treatments.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

AI-driven drug discovery platform for rapid development of novel therapeutics.

Mapping cell-cell communication at scale in human tissue.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

Developing novel protein engineering tools for advanced biomanufacturing and therapeutics.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI-powered drug discovery and development platform for biologics.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

Mining biological information for transformative peptide medicines.

Gene therapy company developing treatments for rare inherited diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Global marketplace connecting researchers with human biospecimens for life science research.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

AI-powered platform for designing novel molecular structures for new medicines.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

Biostax provides a cloud-based platform for life sciences research, enabling data integration and analysis.

SNIPR Biome is a clinical-stage company developing CRISPR-based therapeutics to precisely target and eliminate specific bacteria in the human microbiome.

AI-powered platform accelerating biological research and drug discovery.

Life science company pioneering drug discovery with AI and advanced technologies.